Roivant Sciences ROIV
NASDAQ ROIV
$41.43 -0.05 (-0.12%)
As of: Sep 9, 2026 · 11:14 AM EDT

Roivant Sciences (ROIV) Receivables - Net (2021 - 2024)

Roivant Sciences' (ROIV) quarterly Receivables - Net came in at $678000.0 in Q4 2024, down 98.35% on a YoY basis from $41.1 million in Q1 2024, and down 64.61% quarter-over-quarter from $1.9 million in Q3 2024.

Analysis

Roivant Sciences (ROIV) Receivables - Net (2021 - 2024) Analysis & Trends

Roivant Sciences (ROIV) has reported Receivables - Net for 4 consecutive years, with $678000.0 the latest figure, recorded in Q4 2024.

  • For the quarter ending Q4 2024, Receivables - Net fell 98.35% year-over-year to $678000.0; the trailing twelve-month figure through Dec 2024 stood at $678000.0 (down 98.35% YoY), and the FY2024 full-year result was $678000.0, down 98.35% from the prior year.
  • Receivables - Net declined to $678000.0 in Q4 2024 per ROIV's latest filing, from $1.9 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $79.8 million in Q2 2024 and bottomed at $678000.0 in Q4 2024.
  • Historically, Receivables - Net has averaged $22.5 million across 4 years, with a median of $11.2 million in 2021.
  • The sharpest annual moves came in 2023 and 2024: Receivables - Net surged 683.37% in 2023, then tumbled 98.35% in 2024.
  • Over 4 years, Receivables - Net stood at $8.9 million in 2021, then jumped by 213.5% to $28.0 million in 2022, then jumped by 46.88% to $41.1 million in 2023, then sank by 98.35% to $678000.0 in 2024.
  • According to Business Quant data, Receivables - Net over the past three periods registered $678000.0, $1.9 million, and $79.8 million for Q4 2024, Q3 2024, and Q2 2024 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 211.68 Bn 197.69 Bn 7.24 Bn
2 Gilead Sciences 180.84 Bn 177.66 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.30 Bn 124.45 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.50 Bn 74.50 Bn 3.93 Bn
5 Argenx Se 61.49 Bn 56.31 Bn 1.37 Bn
6 Moderna 55.01 Bn 49.87 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.08 Bn 30.77 Bn 992.69 Mn
8 Biogen 31.35 Bn 30.06 Bn 1.96 Bn
9 Roivant Sciences 29.87 Bn 29.87 Bn 1.16 Mn
10 Insmed 27.84 Bn 26.68 Bn 358.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 678,000.00
Sep 30, 2024 1.92 Mn
Jun 30, 2024 79.79 Mn
Mar 31, 2024 3.99 Mn
Dec 31, 2023 41.08 Mn
Sep 30, 2023 52.12 Mn
Jun 30, 2023 37.06 Mn
Mar 31, 2023 30.38 Mn
Dec 31, 2022 27.97 Mn
Sep 30, 2022 25.04 Mn
Mar 31, 2022 3.88 Mn
Dec 31, 2021 8.92 Mn
Sep 30, 2021 9.81 Mn
Jun 30, 2021 3.42 Mn
Mar 31, 2021 11.22 Mn